Match each gynecologic malignancy with its most characteristic risk factor or pathogenetic association.
- Type I Endometrial AdenocarcinomaChronic unopposed estrogen exposure (e.g., obesity)
- Type II Endometrial (Serous) Carcinomap53 tumor suppressor gene mutations in an atrophic endometrium
- Cervical Squamous Cell CarcinomaPersistent high-risk human papillomavirus (HPV) infection and tobacco use
- Ovarian Clear Cell CarcinomaEndometriosis
- Vaginal Clear Cell AdenocarcinomaIn utero exposure to diethylstilbestrol (DES)
Answer
Type I Endometrial Adenocarcinoma matches with chronic unopposed estrogen; Type II Endometrial Carcinoma matches with p53 mutations; Cervical Squamous Cell Carcinoma matches with high-risk HPV and tobacco use; Ovarian Clear Cell Carcinoma matches with endometriosis; Vaginal Clear Cell Adenocarcinoma matches with in utero DES exposure.
Each gynecologic malignancy arises from a specific pathophysiologic mechanism. Type I endometrial cancer depends on estrogen stimulation, while Type II is associated with p53 mutations and atrophy. Cervical cancer requires persistent HPV infection, exacerbated by smoking. Ovarian clear cell cancer is linked to the chronic inflammation of endometriosis, and vaginal clear cell adenocarcinoma is a historical consequence of in utero DES exposure.
Step-by-Step Solution
Key Concept
Gynecologic malignancies have distinct risk factors and pathogenetic pathways that guide screening, prevention, and diagnosis.